Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Peruvian (BVL) Pharma Industry Analysis

UpdatedOct 12, 2024
DataAggregated Company Financials
Companies1
  • 7Dn/a
  • 3Mn/a
  • 1Yn/a
  • YTDn/a

Industry Valuation and Performance

Has the Peruvian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 17 Oct 2024S/294.5mS/319.1mS/11.8m25x25x0.9x
Sat, 14 Sep 2024S/294.5mS/319.1mS/11.8m25x25x0.9x
Mon, 12 Aug 2024S/294.5mS/319.1mS/11.8m25x25x0.9x
Wed, 10 Jul 2024S/294.5mS/319.1mS/11.8m25x25x0.9x
Fri, 07 Jun 2024S/294.5mS/319.1mS/11.8m25x25x0.9x
Sun, 05 May 2024S/279.7mS/337.5mS/12.0m23.2x23.2x0.8x
Tue, 02 Apr 2024S/295.9mS/337.5mS/12.0m24.6x24.6x0.9x
Thu, 29 Feb 2024S/295.9mS/337.5mS/12.0m24.6x24.6x0.9x
Sat, 27 Jan 2024S/207.6mS/338.9mS/4.4m47.2x47.2x0.6x
Mon, 25 Dec 2023S/207.6mS/338.9mS/4.4m47.2x47.2x0.6x
Wed, 22 Nov 2023S/207.6mS/338.9mS/4.4m47.2x47.2x0.6x
Fri, 20 Oct 2023S/207.6mS/344.4m-S/3,335,000.00n/a-62.2x0.6x
Sun, 17 Sep 2023S/207.6mS/344.4m-S/3,335,000.00n/a-62.2x0.6x
Tue, 15 Aug 2023S/207.6mS/344.4m-S/3,335,000.00n/a-62.2x0.6x
Thu, 13 Jul 2023S/207.6mS/335.8mS/465.0k446.5x446.5x0.6x
Sat, 10 Jun 2023S/207.6mS/376.2mS/26.6m7.8x7.8x0.6x
Mon, 08 May 2023S/207.6mS/376.2mS/26.6m7.8x7.8x0.6x
Wed, 05 Apr 2023S/207.6mS/363.8mS/11.5m18x18x0.6x
Fri, 03 Mar 2023S/207.6mS/363.8mS/11.5m18x18x0.6x
Sun, 29 Jan 2023S/207.6mS/363.8mS/11.5m18x18x0.6x
Tue, 27 Dec 2022S/207.6mS/363.8mS/11.5m18x18x0.6x
Price to Earnings Ratio

18x


Total Market Cap: S/207.6mTotal Earnings: S/11.5mTotal Revenue: S/363.8mTotal Market Cap vs Earnings and Revenue0%0%0%
Peruvian Pharma Industry Price to Earnings3Y Average 36.5x2023AprilJulyOctober2024AprilJulyOctober
Current Industry PE
    There is only one company in the Peruvian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have declined 4.3% per year.
  • This means that the cost of doing business could be reducing since sales have declined but profits have remained steady.

Industry Comparison

How does Peruvian Pharma compare with similar industries?

PE Market0.19%
Healthcare0%0
Pharma0%0
Pharma0%0
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News